Protara Therapeutics, Inc. Common Stock TARA
$3.85
+0.92%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $26.25
- Implied Upside
- +580.9%
- Price Target Range
- $24.00 – $28.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-20 | OppenheimerLeland Gershell |
Maintains | Outperform | $25 → $28 |
| 2026-05-14 | JP MorganBrian Cheng |
Maintains | Overweight | $27 → $26 |
| 2026-04-29 | HC Wainwright & Co.Andrew S. Fein |
Maintains | Buy | $23 → $27 |
| 2026-03-04 | JP MorganBrian Cheng |
Initiates coverage on | Overweight | $27 |
| 2026-02-10 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $23 |
| 2026-01-07 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $24 |
| 2025-12-03 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $23 |
| 2025-11-19 | HC Wainwright & Co.Andres Y. Maldonado |
Reiterates | Buy | $23 |
| 2025-05-22 | Jones TradingSoumit Roy |
Initiates coverage on | Buy | $21 |
| 2025-04-28 | HC Wainwright & Co.Andres Maldonado |
Reiterates | Buy | $23 |
| 2025-04-16 | ScotiabankGeorge Farmer |
Initiates coverage on | Sector outperform | $12 |
| 2025-03-14 | Cantor FitzgeraldLi Watsek |
Initiates coverage on | Overweight | — |
| 2025-03-11 | LifeSci Capital |
Initiates coverage on | Outperform | $22 |
| 2025-03-06 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2024-12-06 | GuggenheimMichael Schmidt |
Reiterates | Buy | $20 |
| 2024-12-06 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2024-11-14 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2024-08-12 | OppenheimerLeland Gershell |
Maintains | Outperform | $30 → $25 |
| 2024-08-08 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2024-05-06 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2024-04-22 | OppenheimerLeland Gershell |
Maintains | Outperform | $26 → $30 |
| 2024-04-08 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $23 |
| 2024-03-14 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2023-08-04 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2023-07-10 | GuggenheimCharles Zhu |
Assumes | Buy | $22 |
| 2023-05-08 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2023-05-01 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2023-03-09 | HC Wainwright & Co.Andrew Fein |
Reiterates | Buy | $23 |
| 2022-08-10 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $30 → $23 |
| 2022-05-09 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $40 → $30 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.85
- Market Cap
- $225.74 million
- 52-Week Range
- $2.97 – $7.82
- Average Volume
- 379K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.